Improving Access to Parenteral Nutrition (PN) in the Hospital: What the Hospitalist Needs to Know about Supplemental PN, Lipids and Safe Use-Presentation

Video Transcription

Video Summary

This educational symposium covered practical guidance on parenteral nutrition (PN), supplemental parenteral nutrition (SPN), lipid injectable emulsions (ILEs), and safety strategies for hospitalists. Speakers emphasized that PN is a high-alert, complex therapy requiring careful patient selection, reassessment, and multidisciplinary oversight.<br /><br />Key clinical points included when to start PN in adults based on nutritional status and stability, and new evidence showing that in the first week of critical illness, enteral nutrition and PN can have similar outcomes when calories and protein are matched. SPN may help meet calorie/protein goals, but early use is not routinely recommended except in selected patients, such as those with malnutrition.<br /><br />The lipid emulsion portion reviewed available formulations: soybean oil, mixed oil, four-oil, and fish-oil-based products. Benefits include energy delivery, essential fatty acids, and lower osmolarity; risks include essential fatty acid deficiency, liver disease, hypertriglyceridemia, and infusion instability. Shortage guidance was also discussed, with recommendations to prioritize vulnerable patients and resume full dosing when supplies normalize.<br /><br />Finally, the session highlighted standardized or multi-chamber bag PN as a safer option in appropriate patients because it reduces compounding steps and error risk, though individualized formulations remain necessary for many.

Keywords

parenteral nutrition

supplemental parenteral nutrition

lipid injectable emulsions

hospitalist safety

critical illness nutrition

enteral nutrition

multidisciplinary oversight

essential fatty acids

standardized PN